Angiogenic Growth Factor Signaling for Tissue Regeneration

This direction is merged into another direction: growth factor upregulation. Its last version stays readable and citable here.

Version 1 of 113 papers19 conceptsfrozen 2026-10-04

In traditional medicine, wound care often focused on passive protection—creating a barrier to keep pathogens out while the body healed itself. However, a growing body of research across cardiology, orthopedics, and dermatology suggests a shift toward active signaling. Instead of merely shielding a wound, modern therapeutic strategies aim to jumpstart the body’s internal repair machinery by upregulating specific growth factors, most notably Vascular Endothelial Growth Factor (VEGF), to trigger angiogenesis.

The intuition is simple: tissue cannot regenerate without a supply chain. By forcing the growth of new blood vessels (angiogenesis), researchers are able to deliver the oxygen, nutrients, and progenitor cells necessary to rebuild complex structures, from heart muscle to bone.

The Vascular Prerequisite for Repair

The recurring theme across these studies is that angiogenesis is not just a side effect of healing; it is a prerequisite. Whether the injury is a myocardial infarction, a bone fracture, or a radiation-induced skin wound, the recovery rate is tethered to the density of the local capillary network.

For instance, Zhixue Ou and colleagues demonstrated in Chemical characterization of wound ointment (WO) and its effects on fracture repair: a rabbit model that traditional ointments accelerate bone union specifically by upregulating VEGF. This neovascularization provides the metabolic support required for bone remodeling. Similarly, Wenkai Shao showed that by targeting the HIF-1α signaling pathway to promote angiogenesis, it is possible to attenuate bone death (osteonecrosis) caused by steroid use DMOG attenuates steroid-associated endothelial progenitor cell impairment and osteonecrosis of the femoral head via regulating HIF-1α signaling pathway in rabbit.

From Cell Replacement to Paracrine Signaling

A pivotal insight in this field is that therapeutic agents do not always need to become the new tissue; they just need to "talk" to the existing cells. This is known as the paracrine effect.

In a landmark study on heart failure, Zicheng Li and Jun Guo found that when mesenchymal stem cells (MSCs) were transplanted into infarcted hearts, fewer than 1% of the cells actually integrated into the tissue. Yet, the hearts showed massive functional improvement. The reason? The MSCs acted as "bioreactors," releasing a flood of VEGF and bFGF that stimulated the host's own vessels to grow and protect surviving heart cells Paracrine Role for Mesenchymal Stem Cells in Acute Myocardial Infarction.

This "master switch" for protection is often mediated by the PI3K/Akt pathway. Feng Su identified this pathway as essential for the heart-protective effects of ischemic preconditioning, showing that when this signaling is active, the heart upregulates a suite of proangiogenic factors like VEGF and Ang-1 to repair itself Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts.

Bioactive Scaffolds as Signal Reservoirs

If signaling is the key, the next challenge is delivery. Researchers are moving away from inert bandages toward bioactive scaffolds that slowly release these growth-promoting cues.

Broad Clinical Horizons

The versatility of this mechanism is its most striking feature. The same logic of "angiogenesis for repair" is being applied to diverse clinical challenges:

By shifting the focus from the structure of the wound to the signaling environment of the tissue, these researchers have identified a universal lever for regeneration: the growth of new life-sustaining vasculature.

Papers in this version

History & citationVersion 1 · 2026-10-04

Merged into another direction · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_angiogenic_growth_factor_signaling_for_t_377bde28,
  title = {Angiogenic Growth Factor Signaling for Tissue Regeneration},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/angiogenic-growth-factor-signaling-for-tissue-regeneration/rdr_377bde28c6e54182856fbc5542cebfb7},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}

This exact version (version 1, frozen text):

@misc{lacuna_angiogenic_growth_factor_signaling_for_t_377bde28_v1,
  title = {Angiogenic Growth Factor Signaling for Tissue Regeneration},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/angiogenic-growth-factor-signaling-for-tissue-regeneration/rdr_377bde28c6e54182856fbc5542cebfb7/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}